Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",Inverse variance weighted,27,0.92 [0.82-1.04],0.205245948082213
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,27,0.99 [0.96-1.02],0.384136113375703
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,27,0.98 [0.92-1.05],0.628494254649361
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,27,0.73 [0.44-1.20],0.217239963844885
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",Inverse variance weighted,27,0.97 [0.93-1.02],0.205650549648658
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XI Diseases of the digestive system,Crohn's disease NAS,Inverse variance weighted,27,1.21 [1.04-1.41],0.0140966435044021
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,27,0.95 [0.88-1.03],0.213988837964589
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,27,0.95 [0.88-1.02],0.160363400815278
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,27,0.95 [0.90-1.00],0.0667104869186182
LRG1,Leucine-rich alpha-2-glycoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,27,1.01 [0.94-1.09],0.736526881735706
LRG1,Leucine-rich alpha-2-glycoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,Inverse variance weighted,27,0.97 [0.91-1.03],0.288370512244079
LRG1,Leucine-rich alpha-2-glycoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,27,1.00 [0.95-1.05],0.890869345724247
LRG1,Leucine-rich alpha-2-glycoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,27,0.99 [0.95-1.04],0.796388975671959
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter V Mental and behavioural disorders,Depression,Inverse variance weighted,27,1.01 [0.98-1.05],0.464329012391782
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter V Mental and behavioural disorders,Depression or dysthymia,Inverse variance weighted,27,0.99 [0.95-1.04],0.722535280524486
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter VI Diseases of the nervous system,Epilepsy,Inverse variance weighted,27,1.03 [0.97-1.09],0.327799880331296
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,27,0.96 [0.90-1.02],0.184314573745984
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,27,0.98 [0.94-1.03],0.424235574319217
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,27,0.98 [0.94-1.02],0.323486133297676
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,27,1.00 [0.97-1.02],0.746170159049078
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,27,0.99 [0.97-1.02],0.724591055628332
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,27,0.84 [0.69-1.03],0.0860166411308433
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,27,0.99 [0.95-1.03],0.541454222561023
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,27,1.01 [0.95-1.07],0.8003893869387
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,27,1.12 [0.98-1.28],0.102209994249495
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,27,0.94 [0.83-1.06],0.297354017482013
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,27,0.94 [0.81-1.09],0.399386415211031
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,27,0.97 [0.93-1.01],0.166166272143671
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,27,1.01 [0.98-1.04],0.568746326596356
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,27,0.97 [0.94-1.00],0.0640321115700321
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,27,0.96 [0.90-1.02],0.20703627492232
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,27,0.91 [0.82-1.00],0.0617339251534402
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",Inverse variance weighted,27,1.09 [0.94-1.27],0.258565329343494
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,Inverse variance weighted,27,1.00 [0.94-1.07],0.945635236852149
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,Inverse variance weighted,27,1.01 [0.93-1.09],0.861832694501166
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",Inverse variance weighted,27,1.00 [0.81-1.24],0.97062086635018
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,27,0.99 [0.97-1.02],0.688976825454834
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,27,0.98 [0.93-1.04],0.587280700167448
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,27,0.97 [0.95-0.99],0.0107002438162535
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,Inverse variance weighted,27,0.95 [0.93-0.98],0.0008012261499633
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,27,1.02 [0.97-1.07],0.471207352185547
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,27,0.97 [0.93-1.01],0.165402424831078
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,27,1.01 [0.94-1.07],0.875884269397313
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,27,1.02 [0.94-1.10],0.700321728631656
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,27,0.99 [0.92-1.06],0.794623225552934
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,27,0.99 [0.95-1.03],0.661231965411336
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,27,1.01 [0.90-1.14],0.860795000593515
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,27,0.95 [0.86-1.05],0.28344706802631
LRG1,Leucine-rich alpha-2-glycoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,27,1.01 [0.91-1.11],0.921211582523951
